大行評級|花旗:維持阿里巴巴“買入”評級 3月推廣活動支持GMV增長
花旗發表研究報吿指,隨着婦女節購物節初步開局良好,加上阿里巴巴旗下天貓新品發佈季的推動、極具吸引力的100億元春季補貼計劃,以及及時趕上全國人大會議期間宣佈的新“以舊換新”舉措,可能會推動消費意願,令截至3月季度商品交易總額(GMV)實現可觀增長。加上越來越多商家或採用全站推廣吿工具,相信這可能預示着客户管理收入(CMR)將在下一個季度實現穩健增長。
鑑於較高的基數,該行料2025財年第四季CMR的年增長率為5.4%。花旗維持其H股目標價為166港元,美股目標價170美元,評級“買入”不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.